MabVax Therapeutics
Biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.
Launch date
Employees
San Diego California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $11.6m | Post IPO Equity | |
| N/A | $4.1m | Post IPO Equity | |
* | N/A | $2.1m | Post IPO Equity |
$11.0m | Post IPO Equity | ||
* | N/A | Post IPO Equity | |
| Total Funding | €14.7m | ||
Related Content
Recent News about MabVax Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.